Relypsa Reports Positive Topline Results for its 52-Week Phase 2b Trial of Patiromer Redwood City, CA, October 17, 2013 – Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that its Phase 2b trial studying the safety and efficacy of patiromer...
Advanced Cell Diagnostics and Kindstar Global Announce Partnership to Launch Cancer Diagnostic Tests in China HAYWARD, CA & WUHAN, CHINA, Oct. 23, 2013—Advanced Cell Diagnostics, Inc. (ACD) and Kindstar Global (Kindstar) today announced that Kindstar will begin...
Direct Flow Medical® Transcatheter Aortic Valve System Continues To Demonstrate Excellent Outcomes at Six Months in Discover CE Mark Trial Results Featured in Oral Presentation at 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference SAN FRANCISCO,...
Advanced Cell Diagnostics Announces Genoptix® as their First CLIA Certified RNAscope® Service Provider Advanced Cell Diagnostic expands RNAscope® technology access through CLIA Service Provider Program HAYWARD, CA, November 5, 2013—Advanced Cell Diagnostics, Inc....
ReShape Medical® Successfully Meets Endpoints in Weight Loss Device Pivotal Trial ReShape Duo® is First to Achieve Important Milestone in the U.S. SAN CLEMENTE, CA, November 7, 2013 –ReShape Medical,® Inc. today announced that its REDUCE Trial for the ReShape Duo®...
Recent Comments